Company Overview - Organogenesis Holdings Inc. (NASDAQ: ORGO) is a healthcare company focused on developing regenerative therapies for advanced wound care (AWC), surgery, and sports medicine [1] - The AWC segment represents over 90% of the company's revenue [1] Financial Performance - The AWC segment has experienced a contraction of approximately 25% year-over-year [1]